Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Improper Labeling and Storage of Controlled Medication

Lancaster, Ohio Survey Completed on 05-06-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that medications were properly labeled in accordance with professional standards and facility policy. During a reconciliation of controlled substances, surveyors observed that a resident's oxycodone tablets were stored in pill-crusher pouches inside a disposable water cup, with the cup labeled only with the resident's name and medication name written in marker. The pouches themselves lacked any pharmacy label or proper identification, containing only handwritten initials and the number '30'. The staff were unable to verify the exact contents or quantity of the medication in the pouches, and the Director of Nursing confirmed that there was no way to know what the tablets actually were or how many were present, aside from the five tablets remaining in the original prescription bottle. The resident involved had a history of osteoporosis, spinal stenosis, chronic pain, osteoarthritis, and joint pain, and had been prescribed oxycodone 5 mg as needed for pain. The medication policy required that drugs be stored in their original packaging with complete pharmacy labeling, and only the dispensing pharmacy was authorized to transfer or relabel medications. The observed practice of storing and labeling the medication did not comply with these requirements, as the medication was not in its original container and lacked the necessary identifying information.

An unhandled error has occurred. Reload 🗙